SXI Life Sciences
6.857,51
PKT
-11,95
PKT
-0,17
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.22 | Novartis Underweight | Barclays Capital | |
31.01.22 | Roche Overweight | Barclays Capital | |
26.01.22 | Roche Buy | Deutsche Bank AG | |
26.01.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
24.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
17.01.22 | Roche Buy | Deutsche Bank AG | |
14.01.22 | Novartis Equal-weight | Morgan Stanley | |
13.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
11.01.22 | Roche Buy | Deutsche Bank AG | |
07.01.22 | Novartis Neutral | UBS AG | |
04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
04.01.22 | Roche Outperform | Bernstein Research | |
04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
17.12.21 | Novartis Sell | Deutsche Bank AG | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
16.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
15.12.21 | Roche Neutral | UBS AG | |
14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.12.21 | Roche Neutral | Credit Suisse Group | |
13.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
13.12.21 | Novartis Neutral | Credit Suisse Group | |
10.12.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
10.12.21 | Roche Neutral | JP Morgan Chase & Co. | |
07.12.21 | Roche Buy | Jefferies & Company Inc. | |
07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
06.12.21 | Novartis Sell | Deutsche Bank AG |